about
Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysisEndoscopic ultrasound in the diagnosis of chronic pancreatitisGenome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility lociA prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.Diagnosis and treatment of pancreatic exocrine insufficiency.Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations.Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control studyFlavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Interobserver agreement of contrast-enhanced harmonic endoscopic ultrasonography in the evaluation of solid pancreatic lesions.Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.Ethanol intake and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans.Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort.Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohortUnited European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU).Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort.Endoscopic ultrasound elastography.Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort.Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery.Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing CholangitisRisk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.Early and/or immediately full caloric diet versus standard refeeding in mild acute pancreatitis: a randomized open-label trial.Mapping chronic liver disease questionnaire scores onto SF-6D utility values in patients with primary sclerosing cholangitis.Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both?Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition.Pre-diagnostic levels of anionic trypsinogen, cationic trypsinogen, and pancreatic secretory trypsin inhibitor in relation to pancreatic cancer risk.Interobserver agreement of EUS elastography in the evaluation of solid pancreatic lesions.Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmö Preventive Project.Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.Trends in incidence of acute pancreatitis in a Swedish population: is there really an increase?Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study.Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study.
P50
Q27021897-D7721935-992C-403C-BFAD-09F86596E505Q28083855-2B76B1BC-A4E3-4698-8D4A-2F2953C5ECFCQ28943478-D6BF7021-1C8E-42D9-9656-64A056272507Q33382880-1AAF8E69-F6B0-40CA-A44E-522DE5DE7DDBQ34386682-66ABCBA3-EB0A-48A2-B96E-42940332914EQ34409402-422A0EB7-314B-4942-B62F-D006C1F7F7E0Q34511085-2174523F-EF29-4D57-A772-0A9C53930423Q35107146-96B075DC-3362-4DE9-8357-E27EEE313BF7Q35552074-09A28BB9-56AA-444D-BBEB-306239B808F8Q35678042-AADBFB23-25FF-42FD-88BF-C6426CECDFF5Q35800137-99F4B8EA-3EC0-437B-AA79-747BB6E5B9C5Q35835118-9F1063C9-1991-4AD3-988A-F9F10A11618FQ35998414-86744BC9-76EC-4AC1-B63A-20240D2086EAQ36401422-E3C0FFA7-C4AA-478C-83B0-17013673CC80Q36551649-36CE6F87-05D5-4EEF-A99F-1C9AB7B652FFQ37126926-DBE8F23A-2163-419F-9B6A-BF7614D5598BQ37273861-EC90A075-F47D-429C-9544-091773904AE8Q37300010-DB62CC86-9FAD-48D0-8DE8-389829C5BBFEQ37698573-9AE11943-045F-43A0-9897-AB7EFA680FE3Q37958014-52AF4DAC-0B2F-4D20-93B7-29050AF6C484Q38221869-18D4090B-46A3-4C0F-A2AF-0580D4FD7D09Q38560914-0BD1B9AF-71DC-4A3B-8BC3-43BCBFF2A434Q38687797-0A096918-D0F0-46D6-8374-97F80318DE84Q38776633-343C9FC9-3B5B-4A67-8278-6B455125E4F2Q38798488-487EC5C3-14D5-4078-8CB5-0A099683A4C4Q39950579-723C45AD-ABEE-4275-8F69-DD9FC8F8AFFDQ40178424-0C1E99C5-FF25-498E-B407-59AE49FA84C7Q40206266-9B681B01-0871-4352-8A85-9A45C822BD03Q40427202-62580CE7-6CFB-4F96-B0DE-DD7A88FF276DQ40796229-530FAF5B-8072-4E42-9F79-E49EE6097E67Q42113956-07BDC6A0-DB74-47F2-A384-7E7706B64BBDQ42230477-9FB454F8-4477-4D5B-A48E-E5331998A4CDQ42232504-1B34A2A2-732E-4C19-BD4D-248909CE7D44Q43059281-06183842-332B-4796-91A1-2BB1A23E1335Q43231356-C72DFFF2-4A1B-4245-B387-1E8AF9ACB15CQ43291119-4790AFF1-C5A2-47E6-84BF-8764DB542BA9Q43420832-0D78A480-E013-464F-9CAD-963C42D9B87EQ43430730-9F1AC4CA-970E-4ACA-A643-4F74A1C943B3Q43704746-99C9F20D-B14B-4D99-BBE3-D49F86F5A73CQ43745661-960AFA7D-F52D-450C-B0D1-AE20FFE2638D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Björn Lindkvist
@ast
Björn Lindkvist
@en
Björn Lindkvist
@es
Björn Lindkvist
@nl
Björn Lindkvist
@sl
type
label
Björn Lindkvist
@ast
Björn Lindkvist
@en
Björn Lindkvist
@es
Björn Lindkvist
@nl
Björn Lindkvist
@sl
prefLabel
Björn Lindkvist
@ast
Björn Lindkvist
@en
Björn Lindkvist
@es
Björn Lindkvist
@nl
Björn Lindkvist
@sl
P106
P21
P31
P496
0000-0001-7485-0006